2015
DOI: 10.1177/1203475415576860
|View full text |Cite
|
Sign up to set email alerts
|

Intralesional Bleomycin for Warts

Abstract: Patients felt bleomycin to be an effective treatment modality for warts, offering high rates of CR in lesions resistant to more traditional therapies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 25 publications
(4 citation statements)
references
References 38 publications
(50 reference statements)
0
4
0
Order By: Relevance
“…Bleomycin has been successfully used for the treatment of recalcitrant warts [ 11 ]. The most likely mechanism of action of this drug is the creation of unstable free radicals causing single-strand breaks and apoptosis [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Bleomycin has been successfully used for the treatment of recalcitrant warts [ 11 ]. The most likely mechanism of action of this drug is the creation of unstable free radicals causing single-strand breaks and apoptosis [ 12 ].…”
Section: Discussionmentioning
confidence: 99%
“…The most likely mechanism of action of this drug is the creation of unstable free radicals causing single-strand breaks and apoptosis [ 12 ]. Multiple bleomycin administration techniques have been studied with various success rates [ 11 , 13 ]. However, several intralesional bleomycin injections are generally necessary to obtain clearance of the warts [ 14 ].…”
Section: Discussionmentioning
confidence: 99%
“…d) Bleomycin: For 40 years, warts have been treated topically with bleomycin, a cytotoxic drug used in systemic chemotherapy. Warts can either be injected with bleomycin solution or have it applied to the surface then stabbed into the wart [43] .…”
Section: C) 5-fluorouracil (5-fu)mentioning
confidence: 99%
“…Ýòî îòêðûòèå ñòèìóëèðîâàëî ïîèñê íîâûõ ïðîäóêòîâ ìèêðîáíîãî ìåòàáîëèçìà, ïîòåíöèàëüíî îáëàäàþùèõ ïðîòèâîðàêîâîé àêòèâíîñòüþ.  íàñòîÿùåå âðåìÿ ñðåäè ïðîòèâîîïóõîëåâûõ àíòèáèîòèêîâ íàèáîëüøåå ïðàêòè÷åñêîå ïðèìåíåíèå èìåþò àíòðàöèêëèíû (ïðèðîäíûå àíòèáèîòèêè -äàóíîðóáèöèí [3,4], äîêñîðóáèöèí [5,6], àêëàðóáèöèí [7,8], ïîëóñèíòåòè÷åñêèå -èäàðóáèöèí [9,10], ýïèðóáèöèí [11,12], ñèíòåòè÷åñêèå àíàëîãè -àìðóáèöèí [13,14]), à òàêaeå áëåîìèöèíû [15,16], àêòèíîìèöèí D [17,18], ìèòðàìèöèí (àóðåîëîâàÿ êèñëîòà) [19] è ìèòîìèöèí [20]. Íåäàâíî ðàçðåøåíû ê ïðèìåíåíèþ 2 íîâûõ ïðîòèâîîïóõîëåâûõ ïðåïàðàòà íà îñíîâå àíòèáèîòèêîâ: â 2007 ã.…”
mentioning
confidence: 99%